Literature DB >> 1906357

Exacerbation of inflammatory demyelinating polyneuropathy after bone marrow transplantation.

H Openshaw1, D R Hinton, N E Slatkin, P J Bierman, F M Hoffman, D S Snyder.   

Abstract

Two patients with hematologic malignancy and quiescent inflammatory demyelinating polyneuropathy developed severe exacerbations of polyneuropathy at the time of bone marrow transplantation. The clinical course in both patients was progressive despite therapy with immuno-suppressive agents, plasmapheresis, and high dose immunoglobulin. The polyneuropathy resulted in quadriplegia which contributed to the patients' deaths 175 and 48 days after transplantation. Sections of multiple peripheral nerves sampled post mortem in the first case revealed prominent demyelination with heavy infiltration of macrophages and lymphocytes. Immunohistochemical studies demonstrated that most of the lymphocytes were of the CD8+, cytotoxic/suppressor cell class and that many of the Schwann cells expressed class II (HLA-DR) antigen. This report suggests that bone marrow transplantation can exacerbate inflammatory demyelinating polyneuropathy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1906357

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  5 in total

1.  Steroid-responsive chronic inflammatory demyelinating polyradiculoneuropathy post-hematopoietic stem cell transplantation: a case report and literature review.

Authors:  Yunxia Zhao; Xiuying Chen; Wen Zhang; Xiaosheng Fang; Xiaohui Liu; Wei Dong
Journal:  Neurol Sci       Date:  2021-07-31       Impact factor: 3.307

2.  Autologous peripheral blood stem cell transplantation for severe multiple sclerosis.

Authors:  Li Su; Juan Xu; Bing-Xin Ji; Sui-Gui Wan; Cong-Yan Lu; Hui-Qing Dong; Yue-Yi Yu; Dao-Pei Lu
Journal:  Int J Hematol       Date:  2006-10       Impact factor: 2.490

Review 3.  Newer therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Krista Kuitwaard; Pieter A van Doorn
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

4.  Acute demyelinating polyneuropathy after lung transplantation: guillain-barré syndrome or tacrolimus toxicity?

Authors:  Nirmal S Sharma; Keith M Wille; Charles W Hoopes; Enrique Diaz-Guzman
Journal:  Case Rep Transplant       Date:  2014-08-11

Review 5.  Stem Cell Therapy in Neuroimmunological Diseases and Its Potential Neuroimmunological Complications.

Authors:  Franz Felix Konen; Philipp Schwenkenbecher; Konstantin Fritz Jendretzky; Stefan Gingele; Lea Grote-Levi; Nora Möhn; Kurt-Wolfram Sühs; Britta Eiz-Vesper; Britta Maecker-Kolhoff; Corinna Trebst; Thomas Skripuletz; Martin W Hümmert
Journal:  Cells       Date:  2022-07-11       Impact factor: 7.666

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.